Skip to main content
. 2010 Nov 24;6(11):e1001210. doi: 10.1371/journal.ppat.1001210

Table 3. Bacterial strains and plasmids.

Plasmids Genetic Characteristics Properties Source or Reference
Strains
E. coli
DH5α F endA1 hsdR17(rk mk)thi-1λrecA1 gyrA96relA1 rhoA supE44 deoRФ80dlacZΔM15Δ(lacZYA argF)U169 Invitrogen
RosettaGami(DE3). pLysS Δ(ara-leu)7697 ΔlacX74 ΔphoA PvuII phoR araD139 ahpC galE galK rpsL (DE3) F'[lac+ lacIq pro] gor522::Tn10 trxB pLysSRARE (CamR, StrR, TetR) Novagen
D. nodosus Protease produced
VCS1703A D. nodosus serogroup G wild-type, virulent AprV2, AprV5, BprV J. Egerton, University of Sydney
CS101 D. nodosus serogroup G wild-type, benign AprB2, AprB5, BprB D. Stewart, CSIRO Livestock Industries
JIR3740*, JIR3743* VCS1703AaprV2Ωtet(M) AprV5, BprV Double crossover from pJIR2097
JIR3756*, JIR3757* VCS1703AaprV5Ωbla AprV2, BprV Double crossover from pJIR2309
JIR3766*, JIR3767* JIR3740bprVΩerm(B) AprV5 Double crossover from pJIR2275
JIR3768*, JIR3769* JIR3757aprV2Ωbla BprV Double crossover from pJIR2097
JIR3883 JIR3756rrnAΩaprV5+ AprV2, AprV5, BprV Double crossover from pJIR2545
JIR3900 JIR3743Δerm(B)ΩaprV2+tet(M) AprV2, AprV5, BprV Double crossover from pJIR3044
JIR3903*, JIR3905* JIR3743ΔaprV5bprVΩerm(B) None Double crossover from pJIR3060
JIR3907*, JIR3908* VCS1703AΔaprV5bprVΩerm(B) AprV2 Double crossover from pJIR3060
JIR3923 JIR3743Δerm(B)ΩaprB2+tet(M) AprB2, AprV5, BprV Double crossover from pJIR3268
JIR3928 VCS1703AbprVΩerm(B) AprV2, AprV5 Double crossover from pJIR3159
JIR3930 JIR3928Δerm(B)ΩbprV+KanR AprV2, AprV5, BprV Double crossover from pJIR3148
Plasmids Properties
pUC18 Apr lacZ cloning vector [54]
pWSK29 Apr lacZ low copy number cloning vector [55]
pWKS30 Apr lacZ low copy number cloning vector [55]
pWSK129 Kmr lacZ low copy number cloning vector [55]
pET22b Apr lacI cloning vector harbouring T7 promoter and terminator with pBR322 and f1 origin. Novagen
pJIR2097 pWSK29 harbouring 5.2 kb fragment containing aprV2 Ω tetM aprV2 suicide plasmid Recombinant
pJIR2275 pUC18 harbouring 3.4 kb fragment containing bprV Ω erm (B) bprV suicide plasmid Recombinant
pJIR2309 pWSK129 harbouring 3.5 kb fragment containing aprV5Ω bla aprV5suicide plasmid Recombinant
pJIR2545 pWKS30 harbouring 4.8 kb fragment containing D. nodosus rrnA promoter, kanamycin resistance, aprV5, rrnA terminator aprV5 complementation plasmid Recombinant
pJIR3044 pWSK29 harbouring 5.9 kb fragment containing aprV2, erm(B) and 2.3 kb chromosomal region downstream of aprV2 aprV2 complementation plasmid Recombinant
pJIR3060 pWSK29 harbouring 3.75 kb fragment containing 5′fragment of aprV5, erm(B) and 3′fragment of bprV aprV5/bprV suicide plasmid Recombinant
pJIR3148 pWSK29 harbouring 4.3 kb fragment containing 3′ fragment of aprV5, kanamycin resistance, bprV bprV complementation plasmid Recombinant
pJIR3159 pWSK29 harbouring 3.5 kb fragment containing bprV Ω erm(B) bprV suicide plasmid Recombinant
pJIR3268 pWSK29 harbouring a 5.9 kb fragment containing aprB2, erm(B) and 2.3 kb chromosomal region downstream of aprV2 aprB2 complementation plasmid Recombinant
pET22b-AprV2 pET22b harbouring 1.4 kb fragment encoding 1–474 residues of the AprV2 precursor. AprV2 expression Recombinant
pET22b-AprB2 pET22b harbouring 1.4 kb fragment encoding 1–474 residues of the AprB2 precursor. AprB2 expression Recombinant
pET22b-AprV2.Y92F pET22b harbouring 1.4 kb fragment encoding 1–474 residues of the AprV2 precursor with a Y92F substitution. AprV2.Y92F expression Recombinant
pET22b-AprV2.Y92D pET22b harbouring 1.4 kb fragment encoding 1–474 residues of the AprV2 precursor with a Y92D substitution. AprV2.Y92D expression Recombinant
pET22b-AprV2.Y92L pET22b harbouring 1.4 kb fragment encoding 1–474 residues of the AprV2 precursor with a Y92L substitution. AprV2.Y92L expression Recombinant
pET22b-AprV2.Y92A pET22b harbouring 1.4 kb fragment encoding 1–474 residues of the AprV2 precursor with a Y92A substitution. AprV2.Y92A expression Recombinant
pET22b-AprV2.C141S pET22b harbouring 1.4 kb fragment encoding 1–474 residues of the AprV2 precursor with a C141S substitution. AprV2.C141S expression Recombinant

*Independently derived mutants.